Literature DB >> 11791813

Open access neuroimaging for general practitioners--diagnostic yield and influence on patient management.

Philip M White1, Jacqueline C Halliday-Pegg, Donald A Collie.   

Abstract

This study assessed the first year of a regional general practitioner (GP) open-access neuroimaging service, to determine diagnostic yield and influence on patient management. Overall, 48.1% of examinations demonstrated a radiologically significant abnormality with 64.1% of spinal imaging examinations demonstrating significant findings. Utilised appropriately, a regional open-access neuroimaging service has good diagnostic yield and may influence the management of most referred patients.

Entities:  

Mesh:

Year:  2002        PMID: 11791813      PMCID: PMC1314198     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  6 in total

1.  The diagnostic yield of magnetic resonance imaging (MRI) of the brain and spine requested by general practitioners: comparison with hospital clinicians.

Authors:  D A Collie; R J Sellar; J P Steyn; R E Cull
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

2.  Early x ray for low back pain confers little benefit.

Authors:  A Ferriman
Journal:  BMJ       Date:  2000-12-16

3.  Direct access to CT screening.

Authors:  S E Kearney; C F Loughran
Journal:  Br J Gen Pract       Date:  1996-05       Impact factor: 5.386

4.  The diagnostic yield of intravenous urography: a demographic study.

Authors:  D A Collie; A B Paul; S R Wild
Journal:  Br J Urol       Date:  1994-06

5.  Influence on patient management of general practitioner direct access to radiological services.

Authors:  E Barton; S Gallagher; C D Flower; R Hanka; R H King; T Sherwood
Journal:  Br J Radiol       Date:  1987-09       Impact factor: 3.039

6.  Secondary care beyond Tomlinson: an opportunity to be seized or squandered?

Authors:  F Moss; M McNicol
Journal:  BMJ       Date:  1992-11-14
  6 in total
  12 in total

1.  'I saw a great star, most splendid and beautiful': headache in primary care.

Authors:  Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

2.  Racism and general practice--time to grasp the nettle.

Authors:  Gilles de Wildt; Paramjit Gill; Sylvia Chudley; Iona Heath
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

3.  A murky future for academic primary care.

Authors:  John J Frey
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

4.  Who should provide primary care for children?

Authors:  C M Ni Bhrolchain
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

5.  Imaging in primary care.

Authors:  Graham Cherryman
Journal:  Br J Gen Pract       Date:  2006-08       Impact factor: 5.386

6.  The use of neuroimaging in dementia by Irish general practitioners.

Authors:  A S Ciblis; M-L Butler; A L W Bokde; P G Mullins; J P McNulty
Journal:  Ir J Med Sci       Date:  2015-06-06       Impact factor: 1.568

7.  Should GPs have direct access to neuroradiological investigation when adults present with headache?

Authors:  David Kernick; Stuart Williams
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

8.  Primary care access to computed tomography for chronic headache.

Authors:  Ralph Thomas; Alan Cook; Gavin Main; Tom Taylor; Elizabeth Galizia Caruana; Robert Swingler
Journal:  Br J Gen Pract       Date:  2010-06       Impact factor: 5.386

9.  Impact of GP direct-access computerised tomography for the investigation of chronic daily headache.

Authors:  Graeme C Simpson; Kirsten Forbes; Evelyn Teasdale; Alok Tyagi; Celestine Santosh
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

10.  Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Authors:  Claire Friedemann Smith; Alice C Tompson; Nicholas Jones; Josh Brewin; Elizabeth A Spencer; Clare R Bankhead; Fd Richard Hobbs; Brian D Nicholson
Journal:  Br J Gen Pract       Date:  2018-08-13       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.